BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6673124)

  • 1. Disappearance of measles antibody in Thai infants after birth.
    Vanprapar N; Chavalittamrong B; Chearskul S; Pimolpan V
    Southeast Asian J Trop Med Public Health; 1983 Dec; 14(4):488-90. PubMed ID: 6673124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity.
    Maldonado YA; Lawrence EC; DeHovitz R; Hartzell H; Albrecht P
    Pediatrics; 1995 Sep; 96(3 Pt 1):447-50. PubMed ID: 7651776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles antibody levels from birth to 9 months of age in Nigerian infants.
    Abdurrahman MB; Greenwood BM; Olafimihan O; Whitle HC
    Afr J Med Med Sci; 1982 Sep; 11(3):113-5. PubMed ID: 6307026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age of measles immunization in tropics.
    Mirchamsy H; Shafyi A; Mahinpour M; Nazari P
    Dev Biol Stand; 1978; 41():191-4. PubMed ID: 572788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal age for vaccinating Nigerian children against measles. I. Neonatal antibody profile and subsequent susceptibility to measles.
    Harry TO; Ogunmekan DA
    Trop Geogr Med; 1981 Dec; 33(4):375-8. PubMed ID: 7342384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response after measles immunization.
    Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental transfer of measles antibodies: effect of gestational age and maternal vaccination status.
    Linder N; Tallen-Gozani E; German B; Duvdevani P; Ferber A; Sirota L
    Vaccine; 2004 Mar; 22(11-12):1509-14. PubMed ID: 15063576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Girls may have lower levels of maternal measles antibodies and higher risk of subclinical measles infection before the age of measles vaccination.
    Martins C; Bale C; Garly ML; Rodrigues A; Lisse IM; Andersen A; Eriksson M; Benn CS; Whittle H; Aaby P
    Vaccine; 2009 Aug; 27(38):5220-5. PubMed ID: 19596409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal age for vaccinating Nigerian children against measles. II. Seroconversion to measles vaccine in different age groups.
    Ogunmekan DA; Harry TO
    Trop Geogr Med; 1981 Dec; 33(4):379-82. PubMed ID: 7342385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles antibody in mothers and infants 0-2 years and response to measles vaccine at the age of 9 and 18 months.
    Techasena W; Sriprasert P; Pattamadilok S; Wongwacharapipoon P
    J Med Assoc Thai; 2007 Jan; 90(1):106-12. PubMed ID: 17621740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles immunity in the first year after birth and the optimum age for vaccination in Kenyan children. Collaborative study by the Ministry of Health of Kenya and the World Health Organization.
    Bull World Health Organ; 1977; 55(1):21-31. PubMed ID: 302153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles immunity after revaccination: results in children vaccinated before 10 months of age.
    Linnemann CC; Dine MS; Roselle GA; Askey PA
    Pediatrics; 1982 Mar; 69(3):332-5. PubMed ID: 7063289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up of infants given measles vaccine at 6 months of age: antibody and CMI responses to MMRII at 15 months of age and antibody levels at 27 months of age.
    Carson MM; Spady DW; Beeler JA; Krezolek MP; Audet S; Pabst HF
    Vaccine; 2005 May; 23(25):3247-55. PubMed ID: 15837229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Age of measles vaccination in Lombardy from the results of a seroepidemiological survey in Milan].
    Profeta ML; Ferrante P
    Boll Ist Sieroter Milan; 1978 Sep; 57(4):549-54. PubMed ID: 570046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimum age for measles immunization in Romania.
    Biberi-Moroeanu S; Tiţeica-Boldeanu M; Munţiu A; Petrenco M; Suter C
    Virologie; 1986; 37(1):3-8. PubMed ID: 3962178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The transmission of maternal measles antibodies to newborn infants in the Ivory Coast].
    Rey JL; Lhuillier M; Dem M; Soro B; Saki Z; Davis CE
    Med Trop (Mars); 1991; 51(2):215-8. PubMed ID: 1654494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal antibody inhibits both cellular and humoral immunity in response to measles vaccination at birth.
    Premenko-Lanier M; Hodge G; Rota P; Tamin A; Bellini W; McChesney M
    Virology; 2006 Jul; 350(2):429-32. PubMed ID: 16569419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.